Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Sexual dysfunction after pelvic surgery

International Journal of Impotence Research volume 18, pages 1–18 (2006)Cite this article

Abstract

Pelvic surgeries are among the most common causes of organic sexual dysfunction in men and women. The impact of nerve-sparing surgery on potency has been well documented in radical prostatectomy. However, its impact on potency needs to be evaluated in other pelvic surgeries. Sexual dysfunction is highly prevalent even after multiple technical advances in the field of oncological surgeries. The prevalence varies from 8 to 82%, depending on the type of pelvic surgery. In females, sexual dysfunction has not been evaluated adequately using validated questionnaires. However, in subspecialized circles, treatment for female sexual dysfunction is becoming routine. Currently, physicians have several options for the treatment of erectile dysfunction (ED) in men. Since the introduction of oral PDE-5 inhibitors, oral therapy has become the first-line treatment option for ED, irrespective of etiology. Currently available treatment options for the female sexual dysfunction include estrogens, androgens, phosphodiesterase inhibitors, and dopamine receptor antagonists. Initial reports regarding the role of early rehabilitation are encouraging and may become the part of routine practice in the management of ED after pelvic surgery. In this article, we summarize the sexual dysfunction following pelvic surgeries and their management.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.

  2. Landis SH, Murray T, Bolden S, Wingo PA . Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8–31.

    CAS  PubMed  Google Scholar 

  3. Walsh PC, Partin AW, Epstein JI . Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994; 152: 1831–1836.

    CAS  PubMed  Google Scholar 

  4. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL . Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 1997; 79: 1977–1986.

    CAS  PubMed  Google Scholar 

  5. Walsh PC, Marschke P, Ricker D, Burnett AL . Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000; 55: 58–61.

    CAS  PubMed  Google Scholar 

  6. Mulcahy JJ . Erectile function after radical prostatectomy. Semin Urol Oncol 2000; 18: 71–75.

    CAS  PubMed  Google Scholar 

  7. Quinlan DM, Epstein JI, Carter BS, Walsh PC . Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991; 145: 998–1002.

    CAS  PubMed  Google Scholar 

  8. Sexton WJ, Benedict JF, Jarow JP . Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy. J Urol 1998; 159: 811–815.

    CAS  PubMed  Google Scholar 

  9. Walsh PC, Donker PJ . Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128: 492–497.

    CAS  PubMed  Google Scholar 

  10. Kundu SD et al. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004; 172: 2227–2231.

    PubMed  Google Scholar 

  11. Catalona WJ, Basler JW . Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993; 150: 905–907.

    Article  CAS  PubMed  Google Scholar 

  12. Catalona WJ, Carvalhal GF, Mager DE, Smith DS . Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433–438.

    CAS  PubMed  Google Scholar 

  13. Litwin MS et al. Quality of life before death for men with prostate cancer: results from the CaPSURE database. J Urol 2001; 165: 871–875.

    Article  CAS  PubMed  Google Scholar 

  14. Rabbani F et al. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000; 164: 1929–1934.

    Article  CAS  PubMed  Google Scholar 

  15. Stanford JL et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283: 354–360.

    CAS  PubMed  Google Scholar 

  16. Geary ES, Dendinger TE, Freiha FS, Stamey TA . Incontinence and vesical neck strictures following radical retropubic prostatectomy. Urology 1995; 45: 1000–1006.

    CAS  PubMed  Google Scholar 

  17. Nandipati KC, Raina R, Agarwal A, Zippe CD . Five year potency status after radical prostatectomy: role of oral therapy in erectaids. American Urological Association Annual Meeting 2005 (abstract # 05-AB-5086).

  18. Weldon VE, Tavel FR . Potency-sparing radical perineal prostatectomy: anatomy, surgical technique and initial results. J Urol 1988; 140: 559–562.

    CAS  PubMed  Google Scholar 

  19. Harris MJ . Radical perineal prostatectomy: cost efficient, outcome effective, minimally invasive prostate cancer management. Eur Urol 2003; 44: 303–308.

    PubMed  Google Scholar 

  20. Frazier HA, Robertson JE, Paulson DF . Radical prostatectomy: the pros and cons of the perineal versus retropubic approach. J Urol 1992; 147: 888–890.

    CAS  PubMed  Google Scholar 

  21. Weldon VE, Tavel FR, Neuwirth H . Continence, potency and morbidity after radical perineal prostatectomy. J Urol 1997; 158: 1470–1475.

    CAS  PubMed  Google Scholar 

  22. Guillonneau B et al. Laparoscopic radical prostatectomy: assessment after 550 procedures. Crit Rev Oncol Hematol 2002; 43: 123–133.

    PubMed  Google Scholar 

  23. Rassweiler J et al. Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. J Urol 2003; 169: 1689–1693.

    PubMed  Google Scholar 

  24. Katz R et al. Patient reported sexual function following laparoscopic radical prostatectomy. J Urol 2002; 168: 2078–2082.

    PubMed  Google Scholar 

  25. Stein JP, Skinner DG . Results with radical cystectomy for treating bladder cancer: a ‘reference standard’ for high-grade, invasive bladder cancer. BJU Int 2003; 92: 12–17.

    CAS  PubMed  Google Scholar 

  26. Schlegel PN, Walsh PC . Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol 1987; 138: 1402–1406.

    CAS  PubMed  Google Scholar 

  27. Walsh PC, Mostwin JL . Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br J Urol 1984; 56: 694–697.

    CAS  PubMed  Google Scholar 

  28. Brendler CB et al. Local recurrence and survival following nerve-sparing radical cystoprostatectomy. J Urol 1990; 144: 1137–1140, discussion 1140–1141.

    CAS  PubMed  Google Scholar 

  29. Schoenberg MP et al. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol 1996; 155: 490–494.

    CAS  PubMed  Google Scholar 

  30. Koraitim M, Khalil R . Preservation of urosexual functions after radical cystectomy. Urology 1992; 39: 117–121.

    CAS  PubMed  Google Scholar 

  31. Marshall FF et al. Ileocolic neobladder post-cystectomy: continence and potency. J Urol 1991; 145: 502–504.

    CAS  PubMed  Google Scholar 

  32. Spitz A, Stein JP, Lieskovsky G, Skinner DG . Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique. J Urol 1999; 161: 1761–1764.

    CAS  PubMed  Google Scholar 

  33. Ramon J, Leandri P, Rossignol G, Gautier JR . Preservation of urinary continence and potency after cystoprostatectomy. Prog Clin Biol Res 1992; 378: 125–132.

    CAS  PubMed  Google Scholar 

  34. Horenblas S, Meinhardt W, Ijzerman W, Moonen LF . Sexuality preserving cystectomy and neobladder: initial results. J Urol 2001; 166: 837–840.

    CAS  PubMed  Google Scholar 

  35. Meinhardt W, Horenblas S . Sexuality preserving cystectomy and neobladder (SPCN): functional results of a neobladder anastomosed to the prostate. Eur Urol 2003; 43: 646–650.

    CAS  PubMed  Google Scholar 

  36. Vallancien G et al. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol 2002; 168: 2413–2417.

    PubMed  Google Scholar 

  37. Zippe CD et al. Sexual function after male radical cystectomy in a sexually active population. Urology 2004; 64: 682–685, discussion 685–686.

    PubMed  Google Scholar 

  38. Nordstrom GM, Nyman CR . Male and female sexual function and activity following ileal conduit urinary diversion. Br J Urol 1992; 70: 33–39.

    CAS  PubMed  Google Scholar 

  39. Berman L et al. Seeking help for sexual function complaints: what gynecologists need to know about the female patient's experience. Fertil Steril 2003; 79: 572–576.

    PubMed  Google Scholar 

  40. Stenzl A et al. Rationale and technique of nerve sparing radical cystectomy before an orthotopic neobladder procedure in women. J Urol 1995; 154: 2044–2049.

    CAS  PubMed  Google Scholar 

  41. Stenzl A et al. Anterior exenteration with subsequent ureteroileal urethrostomy in females. Anatomy, risk of urethral recurrence, surgical technique, and results. Eur Urol 1998; 33 (Suppl 4): 18–20.

    PubMed  Google Scholar 

  42. Bjerre BD, Johansen C, Steven K . A questionnaire study of sexological problems following urinary diversion in the female patient. Scand J Urol Nephrol 1997; 31: 155–160.

    CAS  PubMed  Google Scholar 

  43. Zippe CD et al. Female sexual dysfunction after radical cystectomy: a new outcome measure. Urology 2004; 63: 1153–1157.

    PubMed  Google Scholar 

  44. Walsh PC, Lepor H, Eggleston JC . Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983; 4: 473–485.

    CAS  PubMed  Google Scholar 

  45. Burkhard FC, Studer UE . Orthotopic bladder substitution. Curr Opin Urol 2000; 10: 343–349.

    CAS  PubMed  Google Scholar 

  46. Kessler TM et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 2004; 172: 1323–1327.

    PubMed  Google Scholar 

  47. Nandipati KC et al. Impact of neurovascular preservation on female sexual dysfunction following orthoptic radical cystectomy. Thirteeth Annual Meeting with the American Society of Andrology (abstract # 139).

  48. Mazer NA, Leiblum SR, Rosen RC . The brief index of sexual functioning for women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause 2000; 7: 350–363.

    CAS  PubMed  Google Scholar 

  49. Nappi RE et al. Serum allopregnanolone levels relate to FSFI score during the menstrual cycle. J Sex Marital Ther 2003; 29 (Suppl 1): 95–102.

    PubMed  Google Scholar 

  50. Lepine LA et al. Hysterectomy surveillance – United States, 1980–1993. MMWR CDC Surveill Summ 1997; 46: 1–15.

    CAS  PubMed  Google Scholar 

  51. Dennerstein L, Wood C, Burrows GD . Sexual response following hysterectomy and oophorectomy. Obstet Gynecol 1977; 49: 92–96.

    CAS  PubMed  Google Scholar 

  52. Dennerstein L, Wood G, Burrows GD . Sexual dysfunction following hysterectomy. Aust Fam Physician 1977; 6: 535–543.

    CAS  PubMed  Google Scholar 

  53. Bergmark K et al. Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand 2002; 81: 443–450.

    PubMed  Google Scholar 

  54. Jensen PT et al. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer 2004; 100: 97–106.

    PubMed  Google Scholar 

  55. Carmack Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC . Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 2004; 22: 881–889.

    PubMed  Google Scholar 

  56. Helstrom L . Sexuality after hysterectomy: a model based on quantitative and qualitative analysis of 104 women before and after subtotal hysterectomy. J Psychosom Obstet Gynaecol 1994; 15: 219–229.

    CAS  PubMed  Google Scholar 

  57. Helstrom L, Lundberg PO, Sorbom D, Backstrom T . Sexuality after hysterectomy: a factor analysis of women's sexual lives before and after subtotal hysterectomy. Obstet Gynecol 1993; 81: 357–362.

    CAS  PubMed  Google Scholar 

  58. Dodds DT, Potgieter CR, Turner PJ, Scheepers GP . The physical and emotional results of hysterectomy; a review of 162 cases. S Afr Med J 1961; 35: 53–54.

    CAS  PubMed  Google Scholar 

  59. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM . Hysterectomy and sexual functioning. JAMA 1999; 282: 1934–1941.

    CAS  PubMed  Google Scholar 

  60. Dragisic KG, Milad MP . Sexual functioning and patient expectations of sexual functioning after hysterectomy. Am J Obstet Gynecol 2004; 190: 1416–1418.

    PubMed  Google Scholar 

  61. El-Toukhy TA, Hefni M, Davies A, Mahadevan S . The effect of different types of hysterectomy on urinary and sexual functions: a prospective study. J Obstet Gynaecol 2004; 24: 420–425.

    CAS  PubMed  Google Scholar 

  62. Lindsey I, George BD, Kettlewell MG, Mortensen NJ . Impotence after mesorectal and close rectal dissection for inflammatory bowel disease. Dis Colon Rectum 2001; 44: 831–835.

    CAS  PubMed  Google Scholar 

  63. Watts JM, de Dombal FT, Goligher JC . Long-term complications and prognosis following major surgery for ulcerative colitis. Br J Surg 1966; 53: 1014–1023.

    CAS  PubMed  Google Scholar 

  64. Keating JP . Sexual function after rectal excision. ANZ J Surg 2004; 74: 248–259.

    PubMed  Google Scholar 

  65. Banerjee AK . Sexual dysfunction after surgery for rectal cancer. Lancet 1999; 353: 1900–1902.

    CAS  PubMed  Google Scholar 

  66. Mannaerts GH et al. Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Eur J Surg Oncol 2001; 27: 265–272.

    CAS  PubMed  Google Scholar 

  67. Williams JT, Slack WW . A prospective study of sexual function after major colorectal surgery. Br J Surg 1980; 67: 772–774.

    CAS  PubMed  Google Scholar 

  68. Danzi M, Ferulano GP, Abate S, Califano G . Male sexual function after abdominoperineal resection for rectal cancer. Dis Colon Rectum 1983; 26: 665–668.

    CAS  PubMed  Google Scholar 

  69. Havenga K et al. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996; 182: 495–502.

    CAS  PubMed  Google Scholar 

  70. Fazio VW, Fletcher J, Montague D . Prospective study of the effect of resection of the rectum on male sexual function. World J Surg 1980; 4: 149–152.

    CAS  PubMed  Google Scholar 

  71. Enker WE . Total mesorectal excision—the new golden standard of surgery for rectal cancer. Ann Med 1997; 29: 127–133.

    CAS  PubMed  Google Scholar 

  72. Enker WE et al. Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer. World J Surg 1997; 21: 715–720.

    CAS  PubMed  Google Scholar 

  73. Pocard M et al. A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer. Surgery 2002; 131: 368–372.

    PubMed  Google Scholar 

  74. Quah HM, Jayne DG, Eu KW, Seow-Choen F . Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg 2002; 89: 1551–1556.

    CAS  PubMed  Google Scholar 

  75. Sidi AA, Becher EF, Zhang G, Lewis JH . Patient acceptance of and satisfaction with an external negative pressure device for impotence. J Urol 1990; 144: 1154–1156.

    CAS  PubMed  Google Scholar 

  76. Soderdahl DW, Thrasher JB, Hansberry KL . Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction. Br J Urol 1997; 79: 952–957.

    CAS  PubMed  Google Scholar 

  77. Blackard CE, Borkon WD, Lima JS, Nelson J . Use of vacuum tumescence device for impotence secondary to venous leakage. Urology 1993; 41: 225–230.

    CAS  PubMed  Google Scholar 

  78. Jeremy JY et al. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 1997; 79: 958–963.

    CAS  PubMed  Google Scholar 

  79. Stief CG, Wetterauer U . Erectile responses to intracavernous papaverine and phentolamine: comparison of single and combined delivery. J Urol 1988; 140: 1415–1416.

    CAS  PubMed  Google Scholar 

  80. Lee LM, Stevenson RW, Szasz G . Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. J Urol 1989; 141: 549–550.

    CAS  PubMed  Google Scholar 

  81. Raina R et al. Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 2003; 15: 318–322.

    CAS  PubMed  Google Scholar 

  82. Lakin MM et al. Intracavernous injection therapy: analysis of results and complications. J Urol 1990; 143: 1138–1141.

    CAS  PubMed  Google Scholar 

  83. Mulhall JP et al. The causes of patient dropout from penile self-injection therapy for impotence. J Urol 1999; 162: 1214–1291.

    Google Scholar 

  84. Padma-Nathan H et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med 1997; 336: 1–7.

    CAS  PubMed  Google Scholar 

  85. Costabile RA et al. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol 1998; 160: 1325–1328.

    CAS  PubMed  Google Scholar 

  86. Porst H . Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil—a comparative study in 103 patients with erectile dysfunction. Int J Impot Res 1997; 9: 187–192.

    CAS  PubMed  Google Scholar 

  87. Raina R et al. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 2004; 17: 86–90.

    Google Scholar 

  88. Zippe CD et al. Role of Viagra after radical prostatectomy. Urology 2000; 55: 241–245.

    CAS  PubMed  Google Scholar 

  89. Raina R et al. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 2003; 62: 110–115.

    PubMed  Google Scholar 

  90. Raina R et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 2004; 63: 960–966.

    PubMed  Google Scholar 

  91. Padma-Nathan H et al. On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. Int J Impot Res 2001; 13: 2–9.

    CAS  PubMed  Google Scholar 

  92. Montorsi F et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 2004; 172: 1036–1041.

    CAS  PubMed  Google Scholar 

  93. Brock G et al. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 2003; 170: 1278–1283.

    CAS  PubMed  Google Scholar 

  94. Nandipati KC, Raina R, Agarwal A, Zippe CD . Efficacy and treatment satisfaction of PDE-5 inhibitors in management of erectile dysfunction following radical prostatectomy: SHIM analysis. 30th Annual Meeting with the American Society of Andrology 2005 (abstract # 99).

  95. Padma-Nathan H et al. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003; 169 (Suppl): 375, abstract 1402.

    Google Scholar 

  96. Raina R, Klepacz H, Agarwal A, Zippe CD . Early use of vacuum constriction device (VCD) following radical prostatectomy (RP) facilitates early sexual activity and potential return of erection. J Urol 2002; 167 (Suppl): 279, abstract 1099.

    Google Scholar 

  97. Montorsi F et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158: 1408–1410.

    CAS  PubMed  Google Scholar 

  98. Quinlan DM, Nelson RJ, Walsh PC . Cavernous nerve grafts restore erectile function in denervated rats. J Urol 1991; 145: 380–383.

    CAS  PubMed  Google Scholar 

  99. Walsh PC . Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy. Urology 2001; 57: 1020–1024.

    CAS  PubMed  Google Scholar 

  100. Kim ED et al. Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up. Urology 2001; 58: 983–987.

    CAS  PubMed  Google Scholar 

  101. Anastasiadis AG et al. Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible. Prostate Cancer Prostatic Dis 2003; 6: 56–60.

    CAS  PubMed  Google Scholar 

  102. Lee M, Doolabh VB, Mackinnon SE, Jost S . FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve 2000; 23: 633–640.

    CAS  PubMed  Google Scholar 

  103. Sezen SF, Blackshaw S, Steiner JP, Burnett AL . FK506 binding protein 12 is expressed in rat penile innervation and upregulated after cavernous nerve injury. Int J Impot Res 2002; 14: 506–512.

    CAS  PubMed  Google Scholar 

  104. Lin CS et al. Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms. BJU Int 2002; 89: 955–960.

    CAS  PubMed  Google Scholar 

  105. Lee MC et al. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002; 167: 761–767.

    CAS  PubMed  Google Scholar 

  106. Burnett AL . Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Int J Impot Res 2000; 12: 340.

    PubMed  Google Scholar 

  107. Filippi S et al. Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum. Int J Androl 2003; 26: 101–108.

    CAS  PubMed  Google Scholar 

  108. Kalsi JS, Kell PD, Cellek S, Ralph DJ . NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide. Int J Impot Res 2004; 16: 195–200.

    CAS  PubMed  Google Scholar 

  109. Fourcroy JL . Female sexual dysfunction: potential for pharmacotherapy. Drugs 2003; 63: 1445–1457.

    CAS  PubMed  Google Scholar 

  110. Collins A, Landgren BM . Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study. Maturitas 1994; 20: 101–111.

    CAS  PubMed  Google Scholar 

  111. Basson R . Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 2001; 98: 350–353.

    CAS  PubMed  Google Scholar 

  112. Kaplan SA et al. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999; 53: 481–486.

    CAS  PubMed  Google Scholar 

  113. Geary ES, Dendinger TE, Freiha FS, Stamey TA . Nerve sparing radical prostatectomy: a different view. J Urol 1995; 154: 145–149.

    CAS  PubMed  Google Scholar 

  114. Salomon L et al. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach. Prostate Cancer Prostatic Dis 2002; 5: 285–290.

    CAS  PubMed  Google Scholar 

  115. Varkarakis J, Bartsch G, Horninger W . Long-term morbidity and mortality of transurethral prostatectomy: a 10-year follow-up. Prostate 2004; 58: 248–251.

    PubMed  Google Scholar 

  116. Turk I et al. Laparoscopic radical prostatectomy. Technical aspects and experience with 125 cases. Eur Urol 2001; 40: 46–52.

    CAS  PubMed  Google Scholar 

  117. Hoznek A et al. Laparoscopic radical prostatectomy. The Creteil experience. Eur Urol 2001; 40: 38–45.

    CAS  PubMed  Google Scholar 

  118. Eden CG et al. Laparoscopic radical prostatectomy: the initial UK series. BJU Int 2002; 90: 876–882.

    CAS  PubMed  Google Scholar 

  119. Rassweiler J et al. Laparoscopic radical prostatectomy: functional and oncological outcomes. Curr Opin Urol 2004; 14: 75–82.

    PubMed  Google Scholar 

  120. Tomic R, Sjodin JG . Sexual function in men after radical cystectomy with or without urethrectomy. Scand J Urol Nephrol 1992; 26: 127–129.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA

    C Zippe, K Nandipati, A Agarwal & R Raina

Authors
  1. C Zippe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Nandipati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Raina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Zippe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zippe, C., Nandipati, K., Agarwal, A. et al. Sexual dysfunction after pelvic surgery. Int J Impot Res 18, 1–18 (2006). https://doi.org/10.1038/sj.ijir.3901353

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901353

Keywords

This article is cited by

Search

Advanced search

Quick links